Académique Documents
Professionnel Documents
Culture Documents
ScienceDirect
Review Article
a
Department of Medicine, Mackay Medical College, Taipei, Taiwan
b
Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan
c
Mackay Medicine, Nursing and Management College, Taipei, Taiwan
d
Department of Neonatology, China Medical University Children’s Hospital, Taichung, Taiwan
e
School of Medicine, China Medical University, Taichung, Taiwan
f
Department of Obstetrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan
g
College of Medicine, Chang Gung University, Taoyuan, Taiwan
Received Jan 16, 2017; received in revised form Jun 19, 2017; accepted Sep 1, 2017
Available online 19 September 2017
Key Words Chorioamnionitis is a common cause of preterm birth and may cause adverse neonatal out-
chorioamnionitis; comes, including neurodevelopmental sequelae. Chorioamnionitis has been marked to a het-
intrauterine erogeneous setting of conditions characterized by infection or inflammation or both,
inflammation or followed by a great variety in clinical practice for mothers and their newborns. Recently, a
infection; descriptive term: “intrauterine inflammation or infection or both” abbreviated as “Triple I”
Triple I has been proposed by a National Institute of Child Health and Human Development expert
panel to replace the term chorioamnionitis. It is particularly important to recognize that an
isolated maternal fever does not automatically equate to chorioamnionitis. This article will re-
view the current literature on chorioamnionitis, and introduce the concept of Triple I, as well
as recommendations for assessment and management of pregnant women and their newborns
with a diagnosis of Triple I.
Copyright ª 2017, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
* Corresponding author. Department of Neonatology, China Medical University Children’s Hospital, 2, Yuh-Der Road, Taichung, 404,
Taiwan. Fax: þ886 4 2203 2798.
E-mail address: subh1168@gmail.com (B.-H. Su).
https://doi.org/10.1016/j.pedneo.2017.09.001
1875-9572/Copyright ª 2017, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
232 C.-C. Peng et al
102.2 F, the temperature should be rechecked in 30 min. A immediately on delivery. The disadvantage is that some
repeat temperature 38.0 C or 100.4 F constitutes a biomarkers of placental origin may be higher than neonatal
documented fever.25,37 Oral temperature measurement blood. CRP, procalcitonin, IL-6, IL-8, haptoglobin and
was recommended.38 In labor accompanied with fever and haptoglobin-related protein in cord blood have been widely
unknown GBS status at gestation 37 weeks, intrapartum studied and used in association with hematologic indices to
prophylaxis should be given according to CDC guidelines.32 predict early-onset neonatal sepsis.46e50
The amount of blood that can be safely obtained for
4.2.2. Suspected Triple I biomarkers examination is limited, especially in very low
Without confirmation, Triple I should be qualified with the birth weight infants. Some biomarkers such as CRP and IL-6
term “suspected.” are affected by postnatal physiologic changes that reduce
their specificity.51,52 Blood cultures are known as the gold
4.2.3. Confirmed Triple I standard for early-onset sepsis, however, their use is
To diagnose a confirmed Triple I, infection in amniotic fluid limited by false negative or false-positive results.53 In ad-
(AF) or histopathologic evidence of infection or inflammation ditions, currently there is no established consensus defini-
or both in the placenta, fetal membranes, or the umbilical tion for neonatal sepsis. New biomarkers should be
cord vessels (funisitis) should be proved by laboratory find- developed and evaluated on the basis of neonatal
ings. These findings include positive Gram stain for bacteria outcomes.
in AF, low AF glucose, high WBC count in the absence of a
bloody tap, or positive AF culture results.34,40,41 4.4. Maternal management
inflammation or infection or both while restricting the term 14. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR,
chorioamnionitis to a pathologic diagnosis. Chorioamnioni- Walsh MC, et al. Neonatal outcomes of extremely preterm in-
tis is usually diagnosed based on subjective findings or by fants from the NICHD neonatal research network. Pediatrics
histopathologic examination of the placenta and the um- 2010;126:443e56.
15. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is
bilical cord. To develop more rigorous diagnostic criteria
associated with early survival after preterm birth. Am J Obstet
may better identify those women and their neonates most Gynecol 2004;190:147e51.
likely to benefit from antibiotics treatment and reduce 16. Dammann O, Allred EN, Leviton A, Shen-Schwarz S, Heller D,
unnecessary antibiotic exposure. A prospective study to Genest DR, et al. Fetal vasculitis in preterm newborns: in-
determine whether clinical parameters combined with terrelationships, modifiers, and antecedents. Placenta 2004;
biomarkers accurately predict the presence of Triple I 25:788e96.
would be beneficial to improve maternal and neonatal 17. Redline RW. Inflammatory responses in the placenta and um-
health care. bilical cord. Semin Fetal Neonatal Med 2006;11:296e301.
18. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R,
Yoon BH, et al. Funisitis and chorionic vasculitis: the histo-
Conflict of interest logical counterpart of the fetal inflammatory response syn-
drome. J Matern Fetal Neonatal Med 2002;11:18e25.
None. 19. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The
relationship among inflammatory lesions of the umbilical cord
(funisitis), umbilical cord plasma interleukin 6 concentration,
References amniotic fluid infection, and neonatal sepsis. Am J Obstet
Gynecol 2000;183:1124e9.
1. Su BH. Histologic chorioamnionitis and neonatal outcome in 20. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The
preterm infants. Pediatr Neonatol 2014;55:154e5. relationship between placental histopathology findings and
2. Galinsky R, Polglase GR, Hooper SB, Black MJ, Moss TJ. The perinatal outcome in preterm infants. J Matern Fetal Neonatal
consequences of chorioamnionitis: preterm birth and effects Med 2003;13:102e9.
on development. J Pregnancy 2013;2013:412831. 21. Dexter SC, Malee MP, Pinar H, Hogan JW, Carpenter MW,
3. Bastek JA, Weber AL, McShea MA, Ryan ME, Elovitz MA. Pre- Vohr BR. Influence of chorioamnionitis on developmental
natal inflammation is associated with adverse neonatal out- outcome in very low birth weight infants. Obstet Gynecol 1999;
comes. Am J Obstet Gynecol 2014;210. 450.e1e10. 94:267e73.
4. Higgins RD, Saade G, Polin RA, Grobman WA, Buhimschi IA, 22. Salas AA, Faye-Petersen OM, Sims B, Peralta-Carcelen M,
Watterberg K, et al. Evaluation and management of women Reilly SD, McGwin Jr G, et al. Histological characteristics of the
and newborns with a maternal diagnosis of chorioamnionitis: fetal inflammatory response associated with neuro-
summary of a workshop. Obstet Gynecol 2016;127:426e36. developmental impairment and death in extremely preterm
5. Erdemir G, Kultursay N, Calkavur S, Zekioglu O, Koroglu OA, infants. J Pediatr 2013;163:652e7.
Cakmak B, et al. Histological chorioamnionitis: effects on 23. Malaeb S, Dammann O. Fetal inflammatory response and brain
premature delivery and neonatal prognosis. Pediatr Neonatol injury in the preterm newborn. J Child Neurol 2009;24:
2013;54:267e74. 1119e26.
6. Smulian JC, Shen-Schwarz S, Vintzileos AM, Lake MF, 24. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N
Ananth CV. Clinical chorioamnionitis and histologic placental Engl J Med 2014;370:2211e8.
inflammation. Obstet Gynecol 1999;94:1000e5. 25. Tita AT, Andrews WW. Diagnosis and management of clinical
7. Steel JH, O’donoghue K, Kennea NL, Sullivan MH, Edwards AD. chorioamnionitis. Clin Perinatol 2010;37:339e54.
Maternal origin of inflammatory leukocytes in preterm fetal 26. Lieberman E, Lang J, Richardson DK, Frigoletto FD, Heffner LJ,
membranes, shown by fluorescence in situ hybridisation. Cohen A. Intrapartum maternal fever and neonatal outcome.
Placenta 2005;26:672e7. Pediatrics 2000;105:8e13.
8. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association 27. Evers AC, Nijhuis L, Koster MP, Bont LJ, Visser GH. Intrapartum
of occult amniotic fluid infection with gestational age and fever at term: diagnostic markers to individualize the risk of
neonatal outcome among women in preterm labor. Obstet fetal infection: a review. Obstet Gynecol Surv 2012;67:
Gynecol 1992;79:351e7. 187e200.
9. Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, 28. Impey LW, Greenwood CE, Black RS, Yeh PS, Sheil O, Doyle P.
Cassell GH. Amniotic fluid interleukin-6: correlation with upper The relationship between intrapartum maternal fever and
genital tract microbial colonization and gestational age in neonatal acidosis as risk factors for neonatal encephalopathy.
women delivered after spontaneous labor versus indicated Am J Obstet Gynecol 2008;198:49.
delivery. Am J Obstet Gynecol 1995;173:606e12. 29. Mukhopadhyay S, Dukhovny D, Mao W, Eichenwald EC,
10. Yoon BH, Romero R, Moon J, Chaiworapongsa T, Espinoza J, Puopolo KM. 2010 perinatal GBS prevention guideline and
Kim YM, et al. Differences in the fetal interleukin-6 response to resource utilization. Pediatrics 2014;133:196e203.
microbial invasion of the amniotic cavity between term and 30. Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on
preterm gestation. J Matern Fetal Neonatal Med 2003;13: length of therapy in chorioamnionitis and neonatal sepsis.
32e8. Pediatrics 2014;133:992e8.
11. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The 31. Mukherjee A, Davidson L, Anguvaa L, Duffy DA, Kennea N. NICE
fetal inflammatory response syndrome. Am J Obstet Gynecol neonatal early onset sepsis guidance: greater consistency, but
1998;179:194e202. more investigations, and greater length of stay. Arch Dis Child
12. Parry S, Strauss 3rd JF. Premature rupture of the fetal mem- Fetal Neonatal Ed 2015;100:F248e9.
branes. N Engl J Med 1998;338:663e70. 32. Verani JR, McGee L, Schrag SJ. Division of bacterial diseases,
13. Edwards MS. Postnatal bacterial infections. In: Martin RJ, national center for immunization and respiratory diseases,
Fanaroff AA, Walsh MC, editors. Fanaroff and Martin’s centers for disease control and prevention (CDC). Prevention
neonatal perinatal medicine disease of the fetus and ınfant. of perinatal group B streptococcal diseasedrevised guidelines
8th ed., vol. 2. Philadelphia: Mosby Elsevier; 2006. p. 791e804. from CDC, 2010. MMWR Recomm Rep 2010;59:1e36.
Triple I: A new concept for chorioamnionitis 237
33. Polin RA, Committee on fetus and newborn. Management of asymptomatic short cervix (15 mm) have a high rate of sub-
neonates with suspected or proven early-onset bacterial clinical intraamniotic inflammation: implications for patient
sepsis. Pediatrics 2012;129:1006e15. counseling. Am J Obstet Gynecol 2010;202:433.
34. Redline RW. Inflammatory response in acute chorioamnionitis. 45. Lisonkova S, Sabr Y, Joseph KS. Diagnosis of subclinical amni-
Semin Fetal Neonatal Med 2012;17:20e5. otic fluid infection prior to rescue cerclage using gram stain
35. Polin RA, Randis TM. Chorioamnionitis. In: Martin RJ, and glucose tests: an individual patient meta-analysis. J Obstet
Fanaroff AA, Walsh MC, editors. Fanaroff and Martin’s Gynaecol Can 2014;36:116e22.
neonatal-perinatal medicine. 10th ed. Philadelphia, PA: 46. Steinberger E, Hofer N, Resch B. Cord blood procalcitonin and
Elsevier; 2015. p. 355e64. Interleukin-6 are highly sensitive and specific in the prediction
36. Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 of early-onset sepsis in preterm infants. Scand J Clin Lab
National Institute of Child Health and Human Development Investig 2014;74:432e6.
workshop report on electronic fetal monitoring: update on 47. Cobo T, Kacerovsky M, Andrys C, Drahosova M, Musilova I,
definitions, interpretation, and research guidelines. J Obstet Hornychova H, et al. Umbilical cord blood IL-6 as predictor of
Gynecol Neonatal Nurs 2008;37:510e5. early-onset neonatal sepsis in women with preterm prelabour
37. Avila C, Willins JL, Jackson M, Mathai J, Jabsky M, Kong A, rupture of membranes. PLoS One 2013;8:e69341.
et al. Usefulness of two clinical chorioamnionitis definitions in 48. Howman RA, Charles AK, Jacques A, Doherty DA, Simmer K,
predicting neonatal infectious outcomes: a systematic review. Strunk T, et al. Inflammatory and haematological markers in
Am J Perinatol 2015;32:1001e9. the maternal, umbilical cord and infant circulation in histo-
38. Banerjee S, Cashman P, Yentis SM, Steer PJ. Maternal tem- logical chorioamnionitis. PLoS One 2012;7:e51836.
perature monitoring during labor: concordance and variability 49. Fan Y, Yu JL. Umbilical blood biomarkers for predicting early-
among monitoring sites. Obstet Gynecol 2004;103:287e93. onset neonatal sepsis. World J Pediatr 2012;8:101e8.
39. Genc MR, Ford CE. The clinical use of inflammatory markers 50. Buhimschi CS, Bhandari V, Dulay AT, Nayeri UA, Abdel-
during pregnancy. Curr Opin Obstet Gynecol 2010;22:116e21. Razeq SS, Pettker CM, et al. Proteomics mapping of cord blood
40. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, identifies haptoglobin “switch-on” pattern as biomarker of
Sfakianaki AK, et al. Proteomic profiling of the amniotic fluid to early-onset neonatal sepsis in preterm newborns. PLoS One
detect inflammation, infection, and neonatal sepsis. PLoS Med 2011;6:e26111.
2007;4:e18. 51. Chiesa C, Signore F, Assumma M, Buffone E, Tramontozzi P,
41. Abdel-Razeq SS, Buhimschi IA, Bahtiyar MO, Rosenberg VA, Osborn JF, et al. Serial measurements of C-reactive protein
Dulay AT, Han CS, et al. Interpretation of amniotic fluid white and interleukin-6 in the immediate postnatal period: reference
blood cell count in “bloody tap” amniocenteses in women with intervals and analysis of maternal and perinatal confounders.
symptoms of preterm labor. Obstet Gynecol 2010;116:344e54. Clin Chem 2001;47:1016e22.
42. Sharp GC, Stock SJ, Norman JE. Fetal assessment methods for 52. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F,
improving neonatal and maternal outcomes in preterm prel- Assumma M, et al. C-reactive protein, interleukin-6, and pro-
abour rupture of membranes. Cochrane Database Syst Rev calcitonin in the immediate postnatal period: influence of
2014;(10):CD010209. illness severity, risk status, antenatal and perinatal complica-
43. Aguin E, Aguin T, Cordoba M, Aguin V, Roberts R, Albayrak S, tions, and infection. Clin Chem 2003;49:60e8.
et al. Amniotic fluid inflammation with negative culture and 53. Wynn JL, Wong HR, Shanley TP, Bizzarro MJ, Saiman L,
outcome after cervical cerclage. J Matern Fetal Neonatal Med Polin RA. Time for a neonatal-specific consensus definition for
2012;25:1990e4. sepsis. Pediatr Crit Care Med 2014;15:523e8.
44. Vaisbuch E, Hassan SS, Mazaki-Tovi S, Nhan-Chang CL, 54. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection
Kusanovic JP, Chaiworapongsa T, et al. Patients with an and preterm delivery. N Engl J Med 2000;342:1500e7.